4//SEC Filing
Moss Ronald B. 4
Accession 0001593968-21-000578
CIK 0000887247other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 7:03 PM ET
Size
7.4 KB
Accession
0001593968-21-000578
Insider Transaction Report
Form 4
Moss Ronald B.
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2021-02-21+13,911→ 245,663 total - Exercise/Conversion
Restricted Stock Units
2021-02-21−13,911→ 0 total→ Common Stock (13,911 underlying)
Footnotes (3)
- [F1]Represents the vesting of a portion of previously granted restricted stock units (RSU), with shares of common stock to be issued following vesting of the RSUs as described in the award agreement relating to the RSUs.
- [F2]Includes common stock, as well as restricted stock units granted on January 30, 2019, to the reporting person and previously reported on a Form 4.
- [F3]On February 21, 2018, the reporting person was granted 41,733 restricted stock units. 1/3 of the Restricted Stock Units vest on each anniversary of the grant date over a three year period provided that the Reporting Person has continued to provide services to the Company during such period.
Documents
Issuer
Adamis Pharmaceuticals Corp
CIK 0000887247
Entity typeother
Related Parties
1- filerCIK 0001700786
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 7:03 PM ET
- Size
- 7.4 KB